FDA Inspection
Eurofins PROXY Laboratories B.V.Eurofins PROXY Laboratories B.V. – FDA Inspection, Jul 1, 2022
Record Details
This FDA Inspection record concerns Eurofins PROXY Laboratories B.V., with an inspection on July 1, 2022, issued by the Center for Drug Evaluation and Research, covering drugs.
- Inspection Date
- July 1, 2022
- Product Type
- Drugs
View Company Profile
ID · 39208e98-d17b-4de0-8630-d7c48e4ddbf6
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1272071
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
Other FDA inspections of Eurofins PROXY Laboratories B.V.
4| Date | Classification | Office | Project area |
|---|---|---|---|
| November 10, 2023 | Not classified | Office of Inspections and Investigations | |
| May 1, 2019 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| September 16, 2016 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| March 18, 2013 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Eurofins PROXY Laboratories B.V.
- FDA Inspection 1223518 - 2023-11-10
- FDA Inspection 1142875 - 2019-05-01
- FDA Inspection 987725 - 2016-09-16
- FDA Inspection 823838 - 2013-03-18
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.